NCT02725060
Autoimmune Basis for Postural Tachycardia Syndrome
At risk: Primary completion moved at least 3 months later.
See at-risk trials from Vanderbilt University Medical Center
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 19 versions: 16 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 18 words
- Trial status changed: Enrolling by Invitation → Active, Not Recruiting
- Primary completion pushed from Oct 2026 to Feb 2027
- Study completion pushed from Dec 2026 to Jun 2027
- Notable Primary completion date: Oct 2025 to Oct 2026
- Study completion date: Dec 2025 to Dec 2026
- Notable Primary completion date: Oct 2024 to Oct 2025
- Study completion date: Dec 2024 to Dec 2025
- Notable Primary completion date: Oct 2023 to Oct 2024
- Study completion date: Dec 2023 to Dec 2024
- Minor Primary completion date: Apr 2023 to Oct 2023
- Study completion date: Jul 2023 to Dec 2023
Show 10 earlier versionsHide 10 earlier versions
- Notable Primary completion date: Apr 2022 to Apr 2023
- Study completion date: Jul 2022 to Jul 2023
- Notable Primary completion date: Apr 2021 to Apr 2022
- Study completion date: Jul 2021 to Jul 2022
- Minor Primary completion date: Oct 2020 to Apr 2021
- Study completion date: Dec 2020 to Jul 2021
- Notable Trial status: Suspended to Enrolling by Invitationv9
- Stopped Trial status: Active, Not Recruiting to Suspended Sponsor's reason: Recruitment is temporarily suspended due to COVID-19 outbreak
- Primary completion date: Feb 2020 to Oct 2020
- Study completion date: Jul 2020 to Dec 2020
Minor Trial status: Recruiting to Active, Not Recruitingv7 Show 4 more changesShow less
- Enrollment target: estimated 95 to confirmed 58
- Primary completion date: Feb 2021 to Feb 2020
- Study completion date: Jul 2021 to Jul 2020
- Site details revised at 2 of 2 sites
- Minor Site contacts updated at 1 of 2 sitesv6
- Minor Interventions: 24-hour heart rhythm and blood pressure monitoring (Procedure), 25 micro-Ci of radiation (Radiation), Autonomic function tests (Procedure)… to 24-hour heart rhythm and blood pressure monitoring (Procedure), 25 micro-Ci of radiation (Radiation), Assessment of splanchnic capacitance…v5
- Notable Lead sponsor: Vanderbilt University to Vanderbilt University Medical Centerv4
- Minor Site contacts updated at 1 of 2 sitesv3
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
On up to 3 study days, POTS patients and control subjects will have several tests to assess autonomic function and to detect the presence of autoantibodies to adrenergic receptors. The following tests will de done but in some participants it may not be necessary to do all of them. The investigator will discuss with each participant which particular tests will be done in each particular case: * Posture study with blood samples for autoantibody testing * 24-hour heart rhythm and blood pressure monitoring * autonomic function tests * Quantitative Axonal Sudomotor Reflex Testing * Total blood volume assessment * Pharmacologic testing with phenylephrine * Pharmacologic testing with isoproterenol * Cardiac output with rebreathing * Assessment of splanchnic capacitance * Microneurography
Drugs: phenylephrine, isoproterenol
Radiation: 25 micro-Ci of radiation
Procedures: Posture study with blood samples, 24-hour heart rhythm and blood pressure monitoring, Quantitative Axonal Sudomotor Reflex Testing, Autonomic function tests, microneurography
Other: Rebreathing test, Assessment of splanchnic capacitance
Sites
2 sites in 1 country